PRINTER FRIENDLY
|
In the Spotlight The Adverse-Selection Problem As the Senate prepares to consider health-care reform legislation, a key policy issue remains unsolved: how to prevent what industry insiders call "adverse selection." The bills under consideration, including the one that the Senate Finance Committee recently approved, would impose major restrictions on insurance companies—forcing them to cover anyone, regardless of preexisting health conditions; barring them from setting premiums based on policyholders' health; and limiting how much they could increase premiums because of policyholders' age. These restrictions would lead to a disproportionate number of older, sicker people buying coverage, while the young and healthy delayed buying it until they needed it. That, in turn, would drive up the cost of insurance and threaten one of the legislation's key goals: reducing the number of uninsured. And pricier insurance would doubtless lead to pressure for still more government intervention.
Continue reading . . . News
· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11 Commentary
·
Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11 Research
·
Why States Are So Miffed about Medicaid — Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11 Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research. For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000. Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000. If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line. |
SPOTLIGHT | |
| The Adverse-Selection Problem | |
|
|
|
